Rosalia Viterbo, MD, FACS

- Request Appointment
- Clinical Locations
- About
- Education and Training
- Patient Stories
- Research Profile
- Publications
- Ratings
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Secondary Location
Fox Chase Cancer Center Huntingdon Pike
8 Huntingdon Pike
Rockledge, PA 19046
Associate Professor, Department of Surgical Oncology
Specialties
Treatment Focus
Robotic surgery and adrenal carcinoma
Treatment Philosophy
Coming from a large family, I believe in an approach to cancer care that involves the individual and the family. Personally, I treat my patients the way I would want my family treated—with honesty, compassion and skill.
Joining Fox Chase Cancer Center is the realization of a personal lifelong goal. The Center brings together the perspectives of innovative physicians and researchers to deliver revolutionary and cutting-edge treatment options to everyone. This tradition fits with my longtime dedication to provide patients with the best medical and surgical care.
I came to Fox Chase from City of Hope National Medical Center where I completed my fellowship in a leading robotic oncology program. Having had experience with more than 1,500 robotic prostatectomies, partial nephrectomy, cystectomy and neobladder, indiana pouch and ileal conduit diversions, I have treated patients with various urologic malignancies. I did this through the use of robotics and minimally invasive surgery, as well as open surgery, when appropriate. At Fox Chase, my goal is to continue offering excellent care and leading edge technology, ultimately to benefit the individual outcome and overall quality of life of my patients.
With today's advancing technology, it is critical for me, as a surgeon, to keep current with the expanding base of knowledge and make contributions that translate into reducing the burden of cancer. This starts with the individual and then applies to populations. This knowledge will be invaluable throughout my career as I care for my patients, make decisions, assume leadership responsibilities and respond to complex situations.
Follow on Twitter: @FCUroOnc
Educational Background
- Fellow, Robotic Urologic Oncology, City of Hope National Medical Center, Duarte, CA
- Resident, General Surgery and Urology, Temple University Hospital, Philadelphia, PA
- MD, State University of New York at Buffalo School of Medicine and Biomedical Sciences, 2000
Certifications
- American Board of Urology
Memberships
- Society of Urologic Oncology
- American Urological Association
- Philadelphia Urological Society
- American College of Surgeons
Research Interests
- Prostate cancer
- Robotic and minimally invasive surgery, including prostatectomy, nephrectomy and cystectomy with neobladder and indiana pouch diversion
- Robotic salvage prostatectomy
- Prostate, kidney, bladder and testicular cancer
Selected Publications
Correa AF, Handorf E, Joshi SS, Geynisman DM, Kutikov A, Chen DY, Uzzo RG, Viterbo R, Greenberg RE, Smaldone MC. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database. J Urol, 199(5):1238-44, 2018. PubMed

Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Secondary Location
Fox Chase Cancer Center Huntingdon Pike
8 Huntingdon Pike
Rockledge, PA 19046
Associate Professor, Department of Surgical Oncology
Treatment Focus
Robotic surgery and adrenal carcinoma
Treatment Philosophy
Coming from a large family, I believe in an approach to cancer care that involves the individual and the family. Personally, I treat my patients the way I would want my family treated—with honesty, compassion and skill.
Joining Fox Chase Cancer Center is the realization of a personal lifelong goal. The Center brings together the perspectives of innovative physicians and researchers to deliver revolutionary and cutting-edge treatment options to everyone. This tradition fits with my longtime dedication to provide patients with the best medical and surgical care.
I came to Fox Chase from City of Hope National Medical Center where I completed my fellowship in a leading robotic oncology program. Having had experience with more than 1,500 robotic prostatectomies, partial nephrectomy, cystectomy and neobladder, indiana pouch and ileal conduit diversions, I have treated patients with various urologic malignancies. I did this through the use of robotics and minimally invasive surgery, as well as open surgery, when appropriate. At Fox Chase, my goal is to continue offering excellent care and leading edge technology, ultimately to benefit the individual outcome and overall quality of life of my patients.
With today's advancing technology, it is critical for me, as a surgeon, to keep current with the expanding base of knowledge and make contributions that translate into reducing the burden of cancer. This starts with the individual and then applies to populations. This knowledge will be invaluable throughout my career as I care for my patients, make decisions, assume leadership responsibilities and respond to complex situations.
Follow on Twitter: @FCUroOnc
Education
Educational Background
- Fellow, Robotic Urologic Oncology, City of Hope National Medical Center, Duarte, CA
- Resident, General Surgery and Urology, Temple University Hospital, Philadelphia, PA
- MD, State University of New York at Buffalo School of Medicine and Biomedical Sciences, 2000
Certifications
- American Board of Urology
Memberships
- Society of Urologic Oncology
- American Urological Association
- Philadelphia Urological Society
- American College of Surgeons
Research Profile
Research Interests
- Prostate cancer
- Robotic and minimally invasive surgery, including prostatectomy, nephrectomy and cystectomy with neobladder and indiana pouch diversion
- Robotic salvage prostatectomy
- Prostate, kidney, bladder and testicular cancer
Publications
Selected Publications
Correa AF, Handorf E, Joshi SS, Geynisman DM, Kutikov A, Chen DY, Uzzo RG, Viterbo R, Greenberg RE, Smaldone MC. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database. J Urol, 199(5):1238-44, 2018. PubMed
140 PATIENT COMMENTS